Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 07/27 01:48:07 pm
76.695 EUR   +0.16%
01:30pDJSANOFI : 2Q 2016 -- Forecast
07/26 SANOFI : India ends in green; SC refuses early hearing
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
01:30pDJSANOFI : 2Q 2016 -- Forecast
07/26 SANOFI : India ends in green; SC refuses early hearing
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
07/26SANOFI SA : half-yearly earnings release
07/26 SANOFI PASTEUR : Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses i..
07/25 SANOFI : India zooms 2.7% after strong Q1 nos
07/23 SANOFI INDIA : Q2 NET UP 33% AT Rs85 CRORE
07/22 PROMIS NEUROSCIENCES : Announces Appointment of Dr. Johanne Kaplan as Chief Deve..
07/21 SANOFI : Information concerning the total number of voting rights and shares, pr..
07/21 JUNIPER PHARMACEUTICALS : Appoints Alicia Secor President and Chief Executive Of..
More news
Sector news : Pharmaceuticals - NEC
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J deal
01:22p GSK outlook brightens as Brexit brings currency windfall
01:22p GlaxoSmithKline invests 275 million pounds in UK despite Brexit vote
10:22aDJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- Update
08:55aDJBayer Reports Higher Second-Quarter Profit, Raises Guidance
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/25 Is Biotech Finally Ready To Move Higher?
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
07/22 MannKind - Afrezza Sales Pacing Below My Bearish Line - Reality May Sting
07/22 Re-Evaluation Of LDL Cholesterol-Level Impacts Could Benefit Amarin's Vascepa
07/22 WALL STREET BREAKFAST : Markets Get First Glimpse Of Post-Brexit Data
Advertisement
Financials (€)
Sales 2016 37 154 M
EBIT 2016 9 361 M
Net income 2016 5 093 M
Debt 2016 5 594 M
Yield 2016 3,92%
P/E ratio 2016 17,76
P/E ratio 2017 16,14
EV / Sales 2016 2,81x
EV / Sales 2017 2,76x
Capitalization 98 692 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 85,0 €
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
JÚr˘me Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-2.58%108 516
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results